sales & revops·run 072 · May 2026

Revquota

A governed RevOps AI inventory and evidence workspace that maps actual use, affected people, provider facts, organizational roles, obligations, oversight, and remediation to reviewed legal interpretations.

Genesis score7.34/10

Make Revquota real.0/500

500 more votes and Revquota is authorized for build.

0%500 to authorize

Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.

The opportunity

50 toolsSource catalog target

Aug 2, 2026Passed source milestone

0Verified discovery APIs

The case

A revenue team may deploy AI across prospecting, lead ranking, conversation analysis, routing, pricing, payment terms, hiring-adjacent workflows, and customer decisions, yet a tool name alone cannot determine its legal classification. Revquota discovers and documents actual use, separates provider claims from deployer evidence, and routes each obligation mapping to accountable review. It produces a versioned evidence binder, not an automatic compliance verdict, and it does not convert a sales-tech catalog into fifty pre-decided legal classifications.

Who pays — and why

The RevOps systems leader, privacy or AI governance owner, compliance counsel, or internal-audit team accountable for sales AI inventory and evidence.

What it unlocks

A use-case inventory separating vendor, model, feature, purpose, affected people, decision, and organizational role

Reviewed obligation mappings with authority, version, jurisdiction, assumptions, and exceptions

Evidence requests, owner assignments, approvals, gaps, remediation, and expiry

A reproducible binder that shows what the organization knew and reviewed without certifying compliance

How Genesis scored it

7.34across seven criteria

Temporal window

The source captured a major August 2026 date, but it is now past and legislative timing remains unsettled.

Asymmetric leverage

Inventory, evidence requests, mappings, and binders scale in software while legal review adds cost.

Convergence

One cross-reference and three inbound connections provide limited internal confirmation.

Why it scored well

A major regulatory milestone and a sales-specific inventory gap make the workflow timely, with strong reuse across tools and evidence types.

What's holding it back

The cited August date has passed, pending legislative change can alter timing, the source overgeneralizes high-risk classification, discovery access is unverified, and incumbents can verticalize.

Signals detected5 sources crossed

Signal2026 legal analyses carried in Genesis

Signallegislative analysis carried in Genesis

SignalGenesis market scan

SignalGenesis evidence limitation

Direction briefrevquota.md

revquota.md

Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

No comments yet — be the first to weigh in.